Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints

Horizon Therapeutics, Inc., a privately held biopharmaceutical company, announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT-501, met all primary endpoints.

More: continued here

Filed under: Clinical Trials on December 4th, 2008

Comments are closed.

« New York Times Editorial Says Congress Should Eliminate ‘Unjustified Subsidies’ For Private Medicare Advantage Plans Survival Rates In Advanced Rectal Cancer Patients May Be Improved By Preoperative Radiation »

My Pills Store - Buy Online: My Pills store
Online RX Store - Buy Drugs: Store for Rx products
Order Cheap Pills - Buy Drugs: Order Cheap Pills from online pharmacy.
Pills Store Online - Buy Drugs: Pills sotre online
RX Pills Pharmacy - Buy Drugs: RX pills pharmacy
Soma Drugs - Soma Pills: Soma is a muscle relaxant used to relieve the pain and stiffness of muscle.
Online rx pharma - : Online rx pharma
Latest News...